AINDEX
Markets

BillionToOne, Inc. (BLLN)

BLLNNASDAQ-GSMedical Specialities

$112.00

-2.95 (-2.57%) today

At the close, Nov 10, 4:00 PM ET. After hours $112.00 –

-2.57% 1D
Market cap
$5.35bn
P/E
121.7
EPS, last 4 quarters
$0.9200
Dividend yield
–
Day range
$106.36 to $113.36
52-week range
$61.96 to $150.44
Average volume
588.3k
Previous close
$114.95

Analysts

6 covering

Buy5 buy, 1 hold, 0 sell

Targets a year out average $131.60, +17.5% from here

$120.00now $112.00$145.00

Earnings

next estimate $0.1600

Next report

Dec 2025

+57.1%

Mar 2026

+3300.0%

Jun 2026

0.0%

Sep 2026

+100.0%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$96.05m$108.39m$109.45m$122.98m
Gross profit$68.60m$79.10m$77.11m$87.14m
Operating income$10.33m$17.83m$5.50m$11.02m
Net income$5.98m$17.97m$8.05m$17.39m

Last four quarters: revenue $436.87m, margin 11.3%, free cash flow $33.90m

News

8 latest

The company

Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates (QCT) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level.

Sector
Health Care
Industry
Medical Specialities
Exchange
NASDAQ-GS
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.